Meet Alexander Schuth, M.D., the Chief Operating and Financial Officer of Denali Therapeutics. He joined Denali in 2015 and has a solid track record in the biotech world, being a key player since the company was founded. Before that, he...
Meet Alexander Schuth, M.D., the Chief Operating and Financial Officer of Denali Therapeutics. He joined Denali in 2015 and has a solid track record in the biotech world, being a key player since the company was founded. Before that, he worked at Genentech, where he took on many important roles that helped shape drug development and partnerships. In March 2022, he added the Chief Financial Officer title to his responsibilities. Dr. Schuth has a unique blend of experience in both science and finance, with an M.D. from Charité Medical School in Germany and an M.B.A. from The Wharton School. He also spent time in investment banking, which gives him a strong grip on the financial side of biotech. His focus is on driving Denali's mission to develop treatments for serious diseases, and he currently serves on the board of a biopharmaceutical company, Molecular Health.